DEPODESTA JOHN

Director at INNOVATE Corp. · on record since Feb 3, 2006
Executive Vice President at INNOVATE Corp. · on record since Feb 3, 2006
Director at GENESIS HEALTHCARE CORP · on record since Dec 1, 2006
Director at General Finance CORP · on record since Feb 12, 2015

Insider trading activity of DEPODESTA JOHN

Transactions on record: 33; since Nov 12, 2003

Open-market buys: 4; $123.8K

Open-market sells: 1; $2.3M

Companies traded: 3; last filing Jun 3, 2020

Figures computed from official regulatory filings — .

Companies where DEPODESTA JOHN has traded

General Finance CORP6 tx · Jun 3, 2020
INNOVATE Corp.22 tx · $2.5M · Mar 5, 2010
GENESIS HEALTHCARE CORP5 tx · $849.2K · Jul 17, 2007

Track record of DEPODESTA JOHN

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of DEPODESTA JOHN

Co-insiders of DEPODESTA JOHN

DiVittorio ThomasGeneral Finance CORP +1
HAGER GEORGE V JRGeneral Finance CORP +1
MCKEON JAMES VGeneral Finance CORP +1
RAPPUHN TERRY ALLISONGeneral Finance CORP +1
REITZ ROBERT AGeneral Finance CORP +1
Abraham SpencerGeneral Finance CORP
AIG Capital CORPINNOVATE Corp.
AIG CAPITAL PARTNERS INCINNOVATE Corp.
AIG Global Asset Management Holdings Corp.INNOVATE Corp.
AIG GLOBAL EMERGING MARKETS FUND L L CINNOVATE Corp.
AIG GLOBAL SPORTS & ENTERTAINMENT FUND L PINNOVATE Corp.
AIG GSEF Investments, Ltd.INNOVATE Corp.
AIG GSEF, L.P.INNOVATE Corp.
Allan RobertGeneral Finance CORP
AMERICAN INTERNATIONAL GROUP INCINNOVATE Corp.

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Src
General Finance CORPListing unverified	Jun 3, 2020	Award	124,079	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
General Finance CORPListing unverified	Jun 5, 2019	Award	124,079	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
General Finance CORPListing unverified	Jun 6, 2018	Award	68,650	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
General Finance CORPListing unverified	Jun 8, 2017	Award	52,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
General Finance CORPListing unverified	Jun 9, 2016	Award	40,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
General Finance CORPListing unverified	Jun 5, 2015	Award	19,802	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
INNOVATE Corp.Listing unverified	Mar 5, 2010	ExerciseD (derivative)	-39,746	—	n/a (No price was disclosed in the filing)	SEC
INNOVATE Corp.Listing unverified	Mar 5, 2010	Other	-12,798	6.05	$77.4K	SEC
INNOVATE Corp.Listing unverified	Mar 5, 2010	Exercise	39,746	—	n/a (No price was disclosed in the filing)	SEC
INNOVATE Corp.Listing unverified	Jul 6, 2009	AwardD (derivative)	61,055	—	n/a (No price was disclosed in the filing)	SEC
INNOVATE Corp.Listing unverified	Jul 6, 2009	AwardD (derivative)	19,873	—	n/a (No price was disclosed in the filing)	SEC
INNOVATE Corp.Listing unverified	Jul 6, 2009	AwardD (derivative)	79,492	—	n/a (No price was disclosed in the filing)	SEC
INNOVATE Corp.Listing unverified	Jul 6, 2009	AwardD (derivative)	151,495	—	n/a (No price was disclosed in the filing)	SEC
INNOVATE Corp.Listing unverified	Jul 2, 2009	OtherD (derivative)	-100,000	—	n/a (No price was disclosed in the filing)	SEC
INNOVATE Corp.Listing unverified	Jul 2, 2009	OtherD (derivative)	-120,000	—	n/a (No price was disclosed in the filing)	SEC
INNOVATE Corp.Listing unverified	Jul 2, 2009	OtherD (derivative)	-150,000	—	n/a (No price was disclosed in the filing)	SEC
INNOVATE Corp.Listing unverified	Jul 2, 2009	OtherD (derivative)	-150,000	—	n/a (No price was disclosed in the filing)	SEC
INNOVATE Corp.Listing unverified	Jul 2, 2009	OtherD (derivative)	-430,000	—	n/a (No price was disclosed in the filing)	SEC
INNOVATE Corp.Listing unverified	Jul 2, 2009	OtherD (derivative)	-143,334	—	n/a (No price was disclosed in the filing)	SEC
INNOVATE Corp.Listing unverified	Jul 2, 2009	Other	-151,495	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
INNOVATE Corp.Listing unverified	Mar 5, 2008	AwardD (derivative)	150,000	—	n/a (No price was disclosed in the filing)	SEC
GENESIS HEALTHCARE CORPListing unverified	Jul 17, 2007	Other	-12,245	69.35	$849.2K	SEC
GENESIS HEALTHCARE CORPListing unverified	Dec 1, 2006	Award	2,205	—	n/a (No price was disclosed in the filing)	SEC
INNOVATE Corp.Listing unverified	Feb 3, 2006	AwardD (derivative)	150,000	—	n/a (No price was disclosed in the filing)	SEC
GENESIS HEALTHCARE CORPListing unverified	Dec 2, 2005	Award	2,588	—	n/a (No price was disclosed in the filing)	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
General Finance CORPListing unverified	Jun 3, 2020	Award	124,079	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
General Finance CORPListing unverified	Jun 5, 2019	Award	124,079	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
General Finance CORPListing unverified	Jun 6, 2018	Award	68,650	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
General Finance CORPListing unverified	Jun 8, 2017	Award	52,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
General Finance CORPListing unverified	Jun 9, 2016	Award	40,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
General Finance CORPListing unverified	Jun 5, 2015	Award	19,802	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
INNOVATE Corp.Listing unverified	Mar 5, 2010	ExerciseD (derivative)	-39,746	—	n/a (No price was disclosed in the filing)	SEC
INNOVATE Corp.Listing unverified	Mar 5, 2010	Other	-12,798	6.05	$77.4K	SEC
INNOVATE Corp.Listing unverified	Mar 5, 2010	Exercise	39,746	—	n/a (No price was disclosed in the filing)	SEC
INNOVATE Corp.Listing unverified	Jul 6, 2009	AwardD (derivative)	61,055	—	n/a (No price was disclosed in the filing)	SEC
INNOVATE Corp.Listing unverified	Jul 6, 2009	AwardD (derivative)	19,873	—	n/a (No price was disclosed in the filing)	SEC
INNOVATE Corp.Listing unverified	Jul 6, 2009	AwardD (derivative)	79,492	—	n/a (No price was disclosed in the filing)	SEC
INNOVATE Corp.Listing unverified	Jul 6, 2009	AwardD (derivative)	151,495	—	n/a (No price was disclosed in the filing)	SEC
INNOVATE Corp.Listing unverified	Jul 2, 2009	OtherD (derivative)	-100,000	—	n/a (No price was disclosed in the filing)	SEC
INNOVATE Corp.Listing unverified	Jul 2, 2009	OtherD (derivative)	-120,000	—	n/a (No price was disclosed in the filing)	SEC
INNOVATE Corp.Listing unverified	Jul 2, 2009	OtherD (derivative)	-150,000	—	n/a (No price was disclosed in the filing)	SEC
INNOVATE Corp.Listing unverified	Jul 2, 2009	OtherD (derivative)	-150,000	—	n/a (No price was disclosed in the filing)	SEC
INNOVATE Corp.Listing unverified	Jul 2, 2009	OtherD (derivative)	-430,000	—	n/a (No price was disclosed in the filing)	SEC
INNOVATE Corp.Listing unverified	Jul 2, 2009	OtherD (derivative)	-143,334	—	n/a (No price was disclosed in the filing)	SEC
INNOVATE Corp.Listing unverified	Jul 2, 2009	Other	-151,495	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
INNOVATE Corp.Listing unverified	Mar 5, 2008	AwardD (derivative)	150,000	—	n/a (No price was disclosed in the filing)	SEC
GENESIS HEALTHCARE CORPListing unverified	Jul 17, 2007	Other	-12,245	69.35	$849.2K	SEC
GENESIS HEALTHCARE CORPListing unverified	Dec 1, 2006	Award	2,205	—	n/a (No price was disclosed in the filing)	SEC
INNOVATE Corp.Listing unverified	Feb 3, 2006	AwardD (derivative)	150,000	—	n/a (No price was disclosed in the filing)	SEC
GENESIS HEALTHCARE CORPListing unverified	Dec 2, 2005	Award	2,588	—	n/a (No price was disclosed in the filing)	SEC